Introduction

Insulin antibody is frequently observed in diabetic patients receiving exogenous insulin (1) although, great variations in plasma glucose levels are rarely caused by the presence of insulin antibodies against the administration of exogenous human insulin (2-9). On the other hand, insulin autoimmune syndrome (IAS) is characterized by spontaneous hypoglycemia for antibodies against endogenous insulin without the administration of exogenous insulin (10).
Liver dysfunction is frequently observed in poorly controlled diabetes patients (11) , yet significant elevation of serum aminotransferases is rare in these patients.
Here, we describe a diabetic patient who had two epi- 
sodes of acute liver dysfunction parallel with great variations in plasma glucose levels due to the presence of insulin antibodies against the administration of exogenous human insulin. He was successfully treated with oral glucocorticoid and lispro insulin. Scatchard analysis was performed to investigate the characteristics of the insulin antibody before and after oral glucocorticoid therapy. In addition, the relationship of acute liver dysfunction and uncontrollable glycemia was investigated.
F i g u r e 1 . Hi s t o p a t h o l o g i c a l f i n d i n g s o f t h e l i v e r . Mo d e r a t e g l y c o g e n d e p o s i t s i n t h e n u c l e i o f h e p a t o c y t e s a n d s l i g h t l y m p h o c y t e i n f i l t r a t i o n i n t h e p o r t a l a r e a s a r e s h o wn ( h e ma t o x y l i n a n d e o s i n s t a i n × 1 0 0 ) .
T a b l e 1 . L a b o r a t o r y Da t a o n Au g u s t 1
F i g u r e 2 . Cl i n i c a l c o u r s e o f t h i s p a t i e n t .
A t r a n s i e n t r i s e i n s e r u m a mi n o t r a n s f e r a s e s wa s r e c o g n i z e d a f t e r a r e ma r k a b l e c h a n g e i n t h e p l a s ma g l u c o s e l e v e l .
F i g u r e 3 . S c a t c h a r d a n a l y s i s o f a n t i -i n s u l i n a n t i b o d i e s i n t h e s e r a b e f o r e a n d a f t e r g l u c o c o r t i c o i d t h e r a p y . Re d u c e d b i n d i n g c a p a c i t y o f t h e h i g h a f f i n i t y s i t e o f i n s u l i n a n t i b o d i e s wa s o b s e r v e d a f t e r g l u c o c o r t i c o i d t h e r a p y .
sound scanning showed no liver enlargement or steatosis. The biopsied liver showed moderate glycogen deposits in the nuclei of hepatocytes, slight lymphocyte infiltration in the portal areas and mild derangement of sinusoid architecture (Fig. 1) Fig. 2 . (Fig. 3) . (14) reported a strong correlation between HLA-DRB1 * 406 and IAS, and others have found that DR4, DR7, and B15 are related to insulin antibody against exogenous insulin ; however, this was not seen in the present patient (14, 15) . As Dahl-Jorgensen et al reported increased insulin antibody during continuous subcutaneous insulin infusion and multiple-injection therapy, we treated the present patient with multiple-injection therapy (16) 
Scatchard analysis was performed to investigate the characteristics of the insulin antibody before and after oral glucocorticoid therapy. The reduction of the binding capacity of the high affinity site of insulin antibodies was parallel with oral glucocorticoid therapy
Discussion
In this case, acute liver dysfunction was complicated with uncontrollable glycemia due to the production of an antibody against exogenous human insulin. Insulin antibody is frequently observed in diabetic patients receiving exogenous insulin (1); however, great variations in plasma glucose concentration are rarely caused by the presence of insulin antibodies against the administration of exogenous human insulin (2-9). Theoretically, the production of an antibody against exogenous insulin acts as a buffer because of high affinity and low capacity (12); on the other hand, insulin autoimmune syndrome (IAS) is characterized by spontaneous hypoglycemia for antibodies against endogenous insulin without the administration of exogenous insulin (10). In the present case, we thought that the insulin antibody was produced against exogenous insulin because insulin antibody was negative before the administration of exogenous insulin. In contrast to the insulin antibody against exogenous insulin, in IAS patients it exhibits a much smaller high affinity site and a much larger low capacity site, thereby easily releasing insulin from the antibody (13). Differences in the production mechanisms of insulin antibody against exogenous and endogenous insulin remain to be clarified. Uchigata et al
